SAN DIEGO, May 06, 2022 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Quest Diagnostics Incorporated (“Quest” or the “Company”) ) ( : DGX), its officers, or others have violated federal securities laws by misrepresenting or failing to timely disclose material and adverse information to investors.

What actions can I take at this time? If you purchased Quest securities and suffered significant losses on your investment, contact Johnson Fistel, LLP to submit your losses:

For more information visit our website at https://www.johnsonfistel.com/faq

There is no cost or obligation for you.

What if I have information relevant to the investigation? Individuals with nonpublic information about Quest should consider participating in our investigation or taking advantage of the SEC’s Whistleblower Program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or [email protected].

What is Johnson Fistel investigating? On January 1, 2022, The New York Times published an article regarding the effectiveness of Quest and other testing labs for certain prenatal tests. The article states that these tests produce misleading results and do not properly disclose the chances of a false positive. The article elaborates by stating, “The test is advertised as obtaining positive microdeletion results in 75% of cases. But that figure comes from a single study that included nine confirmed cases of microdeletions, for a test that screens for seven such disorders. The company doesn’t specify how the tests work individually and declined to provide that data. (In a statement, Quest said its test had “excellent performance.”)

Disclaimer: At present, Johnson Fistel has not concluded whether breaches of law may have occurred or whether investors have valid legal rights to recover their losses.

About Johnson Fistel, LLP. Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in securities class actions and derivatives lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Lawyer advertisement. Past results do not guarantee future results.

Follow us on twitter: https://twitter.com/JF_LLP

Contact:

Johnson Fistel, LLP
Jim Baker, Senior Securities Analyst
Telephone: (619) 814-4471
Investor Relations
E-mail: [email protected]